Results 131 to 140 of about 3,650 (207)

Initiating Intramuscular Depot Medroxyprogesterone Acetate Increases Frequencies of Th17-like Human Immunodeficiency Virus Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial. [PDF]

Clin Infect Dis, 2022
Bunjun R, Ramla TF, Jaumdally SZ, Noël-Romas L, Ayele H, Brown BP, Gamieldien H, Harryparsad R, Dabee S, Nair G, Onono M, Palanee-Phillips T, Scoville CW, Heller KB, Baeten JM, Bosinger SE, Burgener A, Passmore JS, Jaspan H, Heffron R.   +19 more
europepmc   +1 more source

Cardiometabolic Risk Marker Changes in Centrally Obese Women Using Depot Medroxyprogesterone Acetate (DMPA) in Kigali, Rwanda. [PDF]

Rwanda J Med Health Sci
Kantarama E, Uwizeye D, Uwineza A.
europepmc   +1 more source

Post-randomization Differences in Condomless Vaginal Sex Among Women Randomized to Intramuscular Depot Medroxyprogesterone Acetate Injections, a Copper Intrauterine Device or a Levonorgestrel Implant in the ECHO Trial. [PDF]

AIDS Behav, 2023
Deese J, Chen PL, Gao X, Heffron R, Hobbs M, Lapple D, Jaspan H, Miller A, Nair G, Onono M, Palanee-Phillips T, Reddy K, Steiner MJ.   +12 more
europepmc   +1 more source

Medroxyprogesterone acetate and meningioma: a global issue

Frontiers in Global Women's Health
Noémie Roland, Sébastien Froelich, Alain Weill   +2 more
doaj   +1 more source

Depot medroxyprogesterone acetate concentrations in patients with and without the use of antiseizure medications. [PDF]

Contraception
Dutton C, Mody SK, Nippita S, Dodge LE, Pang T, Pennell PB, Davis A.   +6 more
europepmc   +1 more source

Regular Use of Depot Medroxyprogesterone Acetate Causes Thinning of the Superficial Lining and Apical Distribution of Human Immunodeficiency Virus Target Cells in the Human Ectocervix. [PDF]

J Infect Dis, 2022
Edfeldt G, Lajoie J, Röhl M, Oyugi J, Åhlberg A, Khalilzadeh-Binicy B, Bradley F, Mack M, Kimani J, Omollo K, Wählby C, Fowke KR, Broliden K, Tjernlund A.   +13 more
europepmc   +1 more source

Acceptance, Adherence, and Side Effects of Depot Medroxyprogesterone Acetate: A Prospective Observational Study. [PDF]

Cureus
Rajaraman R, Vaithilingan S, Selvavinayagam TS.   +2 more
europepmc   +1 more source

Effects of Depot Medroxyprogesterone Acetate Intramuscular Injection, Copper Intrauterine Device and Levonorgestrel Implant Contraception on Estradiol Levels: An Ancillary Study of the ECHO Randomized Trial. [PDF]

Front Glob Womens Health, 2022
Ryan R, Mussa A, Singtaa-Madliki M, Batting J, Balakrishna Y, Morroni C, Hofmeyr GJ.   +6 more
europepmc   +1 more source

Resilient and Accelerated Scale-Up of Subcutaneously Administered Depot-Medroxyprogesterone Acetate in Nigeria (RASuDiN): A Mid-Line Study in COVID-19 Era. [PDF]

Open Access J Contracept, 2021
Osinowo K, Sambo-Donga F, Ojomo O, Ibitoye SE, Oluwayemi P, Okunfulure M, Ladipo OA, Ekholuenetale M.   +7 more
europepmc   +1 more source

Spatial transcriptomics unveils estrogen-modulated immune responses and structural alterations in the ectocervical mucosa of depot medroxyprogesterone acetate users. [PDF]

Sci Rep
Kaldhusdal V, Boger MF, Tjernlund A, Burgener AD, Bradley F, Lajoie J, Omollo K, Kimani J, Fowke K, Czarnewski P, Broliden K.   +10 more
europepmc   +1 more source